# Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery

> clinical trial · VERIFIED · 2026-08-10

Status: ACTIVE_NOT_RECRUITING · Sponsor: Rutgers, The State University of New Jersey · Condition: Stage II Prostate Adenocarcinoma

- Company: Rutgers, The State University of New Jersey
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT02949284

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.